|
Pearl Therapeutics to Present at J.P. Morgan Healthcare Conference
REDWOOD CITY, CALIF, Jan 04, 2013 (GLOBE NEWSWIRE via COMTEX) --
Pearl Therapeutics Inc. today announced that Chuck
Bramlage, the Company's president and CEO will be providing a
corporate and clinical update at the 31st annual J.P. Morgan
Healthcare Conference in San Francisco, CA. Mr. Bramlage's
presentation will include discussion of the Company's inhaled,
fixed-dose combination bronchodilator product candidate, PT003, and
its monotherapy components, PT001 and PT005. Pearl's presentation
will take place on Wednesday, January 9, 2013 at 4:00pm Pacific
Time.
About Pearl Therapeutics
Pearl Therapeutics is a privately held company developing
combination therapies for the treatment of highly prevalent
respiratory diseases, including chronic obstructive pulmonary
disease and asthma. Pearl is rapidly advancing a pipeline of
products including PT003, an inhaled, fixed-dose combination
bronchodilator product comprised of a long-acting muscarinic
antagonist (LAMA) and a long-acting beta-2 agonist (LABA) delivered
via a metered dose inhaler (HFA MDI); and PT010, a
triple-combination product that combines the LAMA and LABA
components of PT003 with an inhaled corticosteroid (ICS) for
twice-daily administration from an HFA MDI for the treatment of
severe COPD. Both PT003 and PT010 are developed with Pearl's
proprietary porous particle co-suspension technology, which allows
the formulation of multiple products in the MDI format, with highly
stable, robust and aerodynamically efficient drug delivery. Founded
in 2006, Pearl Therapeutics is privately held and backed by 5AM
Ventures, Clarus Ventures, New Leaf Ventures and Vatera Healthcare.
For more information, please visit www.pearltherapeutics.com.
CONTACT: Noreen McKiernan
Pearl Therapeutics
(650) 305-2609
nmckiernan@pearltherapeutics.com
Aline Schimmel
Scienta Communications
(312) 238-8957
aschimmel@scientapr.com
http://media.globenewswire.com/cache/19099/small/16659.jpg
http://www.globenewswire.com/newsroom/ti nf=MTMjMTAwMTcwNzQjMTkwOTk=
[ Back To SIP Trunking Home's Homepage ]
|
NEW Bring Your Own Device
(BYOD): HTML5 and Google's WebRTC are
transforming our industry: The disaggregation of the telecom industry has long
been talked about, while available solutions remain
vertically integrated in spite of a growing industry of
standards-based individual components...
NEW SSOA - SIP Service Oriented Architecture™:
Cloud and large enterprise communications
and collaboration infrastructure: This eBook introduces eZuce's SIP Service Oriented
Architecture (SSOA). SSOA is a 'carrier-class'
system that offers the demanding global enterprise
a modern built-for-the-cloud and highly
scalable...
NEW Benefits of Broadvox VAR Partner Program: We built our Partner Program to work for you. We understand that different
types of partners have different needs, and we don't play favorites. When
you partner with Broadvox, every member of our team stands behind you
and your customers 100%... 
What's New?
